Case File
efta-01857565DOJ Data Set 10OtherEFTA01857565
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01857565
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Barrett, Paul S
From:
Jeffrey Epstein
Sent
Fri 10/7/2011 1:47:14 PM
Subject Re: Tax Loss Switches
ok .. you and 1 need to see each other„ the performance speaks for itself.
On Fri, Oct 7, 2011 at 3:46 PM, Barrett, Paul S <E
> wrote:
Jeffrey
Let me know if you would like to do this switch.
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
(W)
(F)
From: Barrett, Paul S
Sent: Thursday. October 06. 2011 11:36 AM
To: 'Jeffrey Epstein'
Cc: Giuffrida, David J
Subject: Tax Loss Switches
Jeffrey
EFTA_R1_00255502
EFTA01857565
We own $6MM (in FT and Haze) of the BAC 8.125% 2049. Currently trading around 80. You could
realize the loss and buy the BAC 8% 2049 with similar call/floating features. Sec below:
SELL
ISSUER:
BANK OF AMERICA CORP
TICKER:
BAC 8.125 12/29/49
PRICE:
79.50
YIELD TO CALL
12.82%
CURRENT YIELD:
10.22%
CUSIP:
060505DT8
BUY
ISSUER:
BANK OF AMERICA CORP
TICKER:
BAC 8.000 12/29/49
YIELD TO CALL
12.57%
CURRENT YIELD:
9.94%
CUSIP:
060505DT8
I would also like to propose that we switch out of GM into a basket of cyclical names that have been
beaten down lately (FCX, HAL, FDX). When you have time I would like to walk you through the
rationale.
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
EFTA_R1_00255503
EFTA01857566
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
(W)
(F)
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://www.jumorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00255504
EFTA01857567
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.jumorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.